UFF
BMRN icon

USA Financial Formulas’s BioMarin Pharmaceuticals BMRN Stock Holding History

USA Financial Formulas’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$283K Buy
+3,336
New +$297K 0.45% 45
2020
Q3 		– Sell
-26,075
Closed -$3.22M – 322
2020
Q2 		$3.22M Buy
+26,075
New +$2.59M 2.39% 15

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

USA Financial Formulas's BMRN Position: Q3 2022 in Review

USA Financial Formulas opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2022: 3,336 shares worth $283K. The stake represents 0.45% of the portfolio and ranks #45 among its holdings. This is a return to the name: USA Financial Formulas previously reported a position in BMRN as recently as Q2 2020.

USA Financial Formulas first reported a position in BMRN in Q2 2020 and has held it in 2 quarters since. The position peaked at $3.22M in Q2 2020. 552 funds tracked by Wall St. Rank hold BMRN as of Q3 2022.

  • USA Financial Formulas held 3,336 shares of BioMarin Pharmaceuticals worth $283K as of Q3 2022.
  • BioMarin Pharmaceuticals was a new USA Financial Formulas position in Q3 2022.
  • BioMarin Pharmaceuticals made up 0.45% of USA Financial Formulas's portfolio in Q3 2022, its #45 holding.
  • USA Financial Formulas first reported a position in BioMarin Pharmaceuticals in Q2 2020 and has held it in 2 quarters since.
  • USA Financial Formulas's BioMarin Pharmaceuticals position peaked at $3.22M in Q2 2020.
  • 552 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2022.

Based on USA Financial Formulas's 13F filing for Q3 2022, filed 24 Oct 2022.